Characteristic upregulation of dopamine D-1-receptor in rat striatum after 6-hydroxydopamine treatment

被引:10
作者
Iwata, S
Shimizu, T
Nomoto, M
Fukuda, T
机构
[1] Department of Pharmacology, Faculty of Medicine
关键词
H-3]SCH23390; 6-hydroxydopamine; upregulation;
D O I
10.1254/jjp.71.255
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We measured the number of D-1-receptors (B-max) in the striatum whose dopaminergic terminals were destroyed to various degrees by 6-hydroxydopamine (6-OHDA) to clarify the relationship between the degree of denervation and the change in B-max for D-1-receptor. Rats were sacrificed 28 days after 6-OHDA treatment, and [H-3]SCH23390 (R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine) binding capacity and monoamine content were measured in striatal homogenate. B-max was significantly upregulated when dopamine content was reduced to less than 5% of that in the vehicle-treated striatum. In contrast, it was significantly decreased when dopamine content was 5-25% of that in the vehicle-treated striatum. The D-1-receptors showed either upregulation or downregulation depending on the degree of denervation.
引用
收藏
页码:255 / 258
页数:4
相关论文
共 50 条
  • [21] Acute versus long-term effects of 6-hydroxydopamine on oxidative stress and dopamine depletion in the striatum of mice
    Varcin, Mustafa
    Bentea, Eduard
    Mertens, Birgit
    Van den Haute, Chris
    Baekelandt, Veerle
    Michotte, Yvette
    Sarre, Sophie
    JOURNAL OF NEUROSCIENCE METHODS, 2011, 202 (02) : 128 - 136
  • [22] Sustained increase in rat myocardial alpha(1A)-adrenoceptors induced by 6-hydroxydopamine treatment involves a decelerated receptor turnover
    Salles, J
    Gascon, S
    Badia, A
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1996, 353 (04) : 408 - 416
  • [23] Effects of simvastatin and 6-hydroxydopamine on histaminergic H1 receptor binding density in rat brains
    Hu, Chang-Hua
    Deng, Chao
    Mackovski, Nikolce
    Long, Ling
    Zhu, Cansheng
    Yang, Yu
    Wang, Yuge
    Chen, Jiezhong
    Huang, Xu-Feng
    Wang, Qing
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (08) : 1419 - 1425
  • [24] Early toxic effect of 6-hydroxydopamine on extracellular concentrations of neurotransmitters in the rat striatum: An in vivo microdialysis study
    Cesar Tobon-Velasco, Julio
    Silva-Adaya, Daniela
    Carmona-Aparicio, Liliana
    Garcia, Esperanza
    Galvan-Arzate, Sonia
    Santamaria, Abel
    NEUROTOXICOLOGY, 2010, 31 (06) : 715 - 723
  • [25] Effect of 6-hydroxydopamine or repeated amphetamine treatment on mesencephalic mRNA levels for AMPA glutamate receptor subunits in the rat
    Bardo, MT
    Robinet, PM
    Mattingly, BA
    Margulies, JE
    NEUROSCIENCE LETTERS, 2001, 302 (2-3) : 133 - 136
  • [26] IN PATIENTS RECEIVING DOPAMINE INFUSIONS FOR TREATMENT OF SHOCK DO FREE-RADICALS CONVERT DOPAMINE TO 6-HYDROXYDOPAMINE
    TONG, J
    BAINES, AD
    CLINICAL BIOCHEMISTRY, 1993, 26 (03) : 199 - 205
  • [27] Effects of dopamine D4 receptor-selective antagonists on motor hyperactivity in rats with neonatal 6-hydroxydopamine lesions
    Zhang, KH
    Davids, E
    Tarazi, FI
    Baldessarini, RJ
    PSYCHOPHARMACOLOGY, 2002, 161 (01) : 100 - 106
  • [28] Repeated administration of high dose levodopa enhances hydroxyl radical production in the rat striatum denervated with 6-hydroxydopamine
    Ishida, Y
    Hashiguchi, H
    Todaka, K
    Ishizuka, Y
    Mitsuyama, Y
    NEUROSCIENCE LETTERS, 2000, 290 (01) : 33 - 36
  • [29] DESMETHYLIMIPRAMINE PRETREATMENT PREVENTS 6-HYDROXYDOPAMINE INDUCED SOMATOSTATIN RECEPTOR REDUCTION IN THE RAT HIPPOCAMPUS
    LOPEZSANUDO, S
    ARILLA, E
    REGULATORY PEPTIDES, 1992, 41 (03) : 227 - 236
  • [30] Altered melatonin MT1 receptor expression in the ventral midbrain following 6-hydroxydopamine lesions in the rat medial forebrain bundle
    Kang, Na Hyea
    Carriere, Candace H.
    Bahna, Sarra G.
    Niles, Lennard P.
    BRAIN RESEARCH, 2016, 1652 : 89 - 96